Heat shock proteins (Hsps) are an evolutionarily conserved group of proteins that are inducible by a wide variety of physical, pathophysiological and environmental stressors (reviewed in Morimoto et al., 1992; Morimoto, 1993) . Hsps are grouped by molecular weight and amino acid sequence similarity into five main families (reviewed in Welch, 1992). Hsp27, a member of the small heat shock protein family, has been shown to play a role in cellular repair and protective mechanisms against cell stress and apoptosis (Jakob et al., 1993; Merck et al., 1993) . For example, Hsp27 over-expression in NIH/3T3 cells confers thermoresistance (Landry et al., 1989) and increases resistance to oxidative stress and cytotoxicity induced by tumor necrosis factor-␣ treatment (Mehlen et al., 1995) . Over-expression of Hsp27 in cultured dorsal root ganglion neurons has been shown to protect neurons from apoptosis after withdrawal of nerve growth factor. In addition, an established neuronal cell line over-expressing Hsp27 was protected from retinoic acid-induced apoptosis (Wagstaff et al., 1999) . In vivo, Lewis et al. (1999) have demonstrated that, following transection of the sciatic nerve in post-natal day 0 rats, all surviving axotomized neurons were Hsp27-positive.
Heat shock proteins (Hsps) are an evolutionarily conserved group of proteins that are inducible by a wide variety of physical, pathophysiological and environmental stressors (reviewed in Morimoto et al., 1992; Morimoto, 1993) . Hsps are grouped by molecular weight and amino acid sequence similarity into five main families (reviewed in Welch, 1992) . Hsp27, a member of the small heat shock protein family, has been shown to play a role in cellular repair and protective mechanisms against cell stress and apoptosis (Jakob et al., 1993; Merck et al., 1993) . For example, Hsp27 over-expression in NIH/3T3 cells confers thermoresistance (Landry et al., 1989) and increases resistance to oxidative stress and cytotoxicity induced by tumor necrosis factor-␣ treatment (Mehlen et al., 1995) . Over-expression of Hsp27 in cultured dorsal root ganglion neurons has been shown to protect neurons from apoptosis after withdrawal of nerve growth factor. In addition, an established neuronal cell line over-expressing Hsp27 was protected from retinoic acid-induced apoptosis (Wagstaff et al., 1999) . In vivo, Lewis et al. (1999) have demonstrated that, following transection of the sciatic nerve in post-natal day 0 rats, all surviving axotomized neurons were Hsp27-positive.
The induction and expression of Hsp27 has been widely studied in the mammalian CNS (Reviewed in Krueger-Naug et al., 2002b) . Hsp27 is highly inducible in cortical astrocytes after seizure activity (Plumier et al., 1996) , ischemic injury (Plumier et al., 1997a) and cortical spreading depression (Plumier et al., 1997b) . Hsp27 is also normally present in many neurons of the brainstem and spinal cord of rat and mouse (Plumier et al., 1997c; Armstrong et al., 2001) . Hsp27 is induced and expressed at very high levels for extended periods of time in vagal sensory and motor neurons after vagal transection (Hopkins et al., 1998) . These results suggest that Hsp27 plays a critical role in normal neuronal metabolism and in neuronal survival.
In the retina, antibodies to this small heat shock protein have been identified in patients with normal pressure and high pressure glaucoma (Tezel et al., 1998) . When applied to retinal tissue, Hsp27 antibodies triggered apoptosis, indicating that Hsp27 itself may inhibit apoptosis when not blocked by its antibody (Tezel and Wax, 2000) . More recently, Yokoyama et al. (2001) have reported that electro-poration of exogenous Hsp27 protein in retinal ganglion cells (RGCs) increased resistance to apoptosis following ischemia-reperfusion injury. We have shown that Hsp27 is not present at detectable levels in control, non-injured rat RGCs. However, following optic nerve transection, Hsp27 is detected in a subset of RGCs from 4 to 28 days (Krueger-Naug et al., 2002a) . We proposed that this expression may contribute to the long-term survival of this subset of RGCs.
Axotomy of the optic nerve causes apoptosis in RGCs that begins at 4 days and results in the loss of most RGCs by 14 days following injury (Berkelaar et al., 1994; GarciaValenzuela et al., 1994; Peinado-Ramó n et al., 1996) . The loss of trophic support is thought to be an important factor contributing to apoptotic RGC death following optic nerve transection (reviewed in Sofroniew, 1999) . Neurotrophins play a significant role in the survival of injured RGCs. Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family and interacts with the cell surface transmembrane receptor tyrosine receptor kinase B (TrkB) to activate intracellular signaling pathways leading to the transcription of regenerative associated genes and the inhibition of apoptosis (reviewed in Heumann, 1994; Segal and Greenberg, 1996; Klö cker et al., 2000) . TrkB is present in the ganglion cell layer on both RGCs and amacrine cells (Jelsma et al., 1993; Vecino et al., 2002) and in vitro treatment with BDNF or neurotrophin 4/5 (NT-4/5) enhances RGC survival (Cohen et al., 1994) . In vivo studies have shown that activation of the TrkB receptor by administration of a single dose of BDNF or NT-4/5 at the time of optic nerve transection increases the number of RGCs surviving at 2 weeks (Mansour-Robaey et al., 1994; Peinado-Ramó n et al., 1996; Sawai et al., 1996) . It is important to note, however, that prolonged administration of neurotrophin does not appear to enhance the survival of RGCs in the long term (Clarke et al., 1998) .
The purpose of this study is to determine whether the administration of BDNF, a neurotrophin known to enhance the survival of axotomized RGCs, has an effect on the RGC expression of Hsp27, an inducible protein that has been implicated in sensory neuron survival.
EXPERIMENTAL PROCEDURES Animals
Young adult female Sprague-Dawley rats (175-250 g; Charles River, St. Constant, QC, Canada) were cared for in accordance with the Guide to the Care and Use of Experimental Animals of the Canadian Council on Animal Care. All surgical procedures were performed under general anesthesia using a mixture of ketamine (62.5 mg/kg), xylazine (3.25 mg/kg) and acepromazine (0.62 mg/ kg) in 0.9% saline, administered by intramuscular injection.
Retinal ganglion cell labeling
One week prior to experimental manipulations, Fluorogold (FG) [2% FG in 0.9% saline; Fluorochrome Inc., Denver, CO] soaked Gelfoam (UpJohn, Don Mills, ON, Canada) was applied to the surface of both superior colliculi to label the cell bodies of RGCs by retrograde transport (Vidal-Sanz et al., 1988; Villegas-Pé rez et al., 1993) .
Optic nerve transection
Following the methods of Mansour-Robaey et al. (1994) and Clarke et al. (1998) , the left optic nerve was transected with microscissors at approximately 0.5 mm from the back of the eye. Preservation of the blood supply was confirmed by microscopic examination of the retina through the pupil. Animals recovered from 0 (normal right eye) 4, 7, 10, 14 and 28 days following transection and intravitreal administration of either BDNF or vehicle (see below; nϭ4 for each group).
Administration of BDNF
To determine the effect of BDNF administration on the expression of Hsp27, BDNF (5 l; 1 g/l in Tris-phosphate buffer; Regeneron, Tarrytown, NY) or vehicle (5 l Tris-phosphate buffer) was injected slowly into the vitreous chamber of the left eye by the posterior approach through the sclera and the retina, at the time of optic nerve transection (Clarke et al., 1998) . Animals in these two treatment groups recovered from 0 (normal right eye), 4, 7, 10, 14 and 28 days (BDNFϭ4, vehicleϭ4 for each group) following optic nerve transection. BDNF and vehicle-injected non-transected controls were also included in this study. These control animals were exposed to the same surgical procedures but the optic nerve was not cut. Control animals recovered for 4 days and 10 days following surgery (nϭ4 for each group).
Tissue processing
At the end of the experimental period, rats were deeply anesthetized with a mixture of ketamine (62.5 mg/kg), xylazine (3.25 mg/kg) and acepromazine (0.62 mg/kg) in 0.9% saline, administered by intramuscular injection. Animals were perfused transcardially with 0.9% saline followed by 4% paraformaldehyde. The left (experimental) and right (normal control) eyes were removed and post-fixed for 24 h in 4% paraformaldehyde then gelatin embedded and cut on a freezing microtome at 30 m.
Immunohistochemistry
Hsp27. Five non-adjacent radial sections of retina through the optic disk were used for Hsp27 immunohistochemical analysis following the method of Krueger-Naug et al. (2002a) . Sections were incubated with phosphate-buffered saline (PBS) containing 0.1% Triton-X (PBS-X) and 10% goat serum for 1 h at room temperature. Primary rabbit polyclonal antibody specific for the murine 25 kDa heat shock protein, Hsp25, and the homologous rat Hsp27 (Plumier et al., 1997c; Krueger-Naug et al., 2000 , 2002a Armstrong et al., 2001 ; StressGen Biotechnologies Corporation, Victoria, BC, Canada) was diluted 1:1000 in PBS-X with 2% goat serum and incubated overnight at 4°C. After three 10-min rinses, sections were incubated for 3 h in PBS (no Triton-X) containing Alexa goat anti-rabbit 546 (1:500; Molecular Probes, Eugene, OR, USA). The sections were rinsed with PBS then floated onto gelatinized slides, air-dried overnight and coverslipped with Fluoromount (BDH Chemicals, Poole, England). FG and Hsp27-immunopositive cell profiles were counted in each experimental case. Retinal ganglion cell type was confirmed by punctate FG-labeling, morphology and location within the ganglion cell layer.
Glial fibrillary acidic protein (GFAP).
To confirm Mü ller cell type, several non-adjacent radial sections through the optic disk were used from the various treatment groups and prepared as above for immunohistochemistry. Sections were incubated overnight at 4°C with 2% goat serum and the monoclonal GFAP antibody [1:200; Vector Laboratories (Nova Castra), Burlington, ON, Canada] in PBS-X. After three 10 min rinses, sections were incubated for 3 h in PBS containing Alexa goat anti-mouse 488 (1:500; Molecular Probes) and processed as above.
Microscopy and image processing. Sections were examined using fluorescence and UV microscopy on a Zeiss Axioplan microscope. Immunofluorescence stained sections were scanned using a Diagnostic Instruments Inc. Spot II digital camera mounted on a Zeiss Axioplan 2 microscope, and images were captured digitally using Adobe Photoshop 5.0 software. Prints and photographic plates were made using a Kodak 8650 printer with continuous tone dye sublimation. Other than brightness and contrast, images were not otherwise adjusted.
Statistical analysis
Total FG and Hsp27-positive RGCs were counted for each animal from a total of five sections through the optic disk per animal and the data are represented as meansϮS.E.M. for each group (nϭ4 animals per group). The non-parametric Mann Whitney U test was used to compare means between the various groups, with significance set at PϽ0.05.
RESULTS

FG labeling
To compare the extent of RGC loss following optic nerve transection and concomitant administration of either BDNF or vehicle, FG-positive RGC profiles were examined in each group (Fig. 1) .
The total number of FG-positive RGCs was counted in five non-adjacent radial sections through the optic disk and the mean total was calculated for each group (nϭ4; Fig. 2 ). At 4 days following optic nerve transection, there was no significant difference in the number of FG-positive RGCs between BDNF (4767Ϯ309; meanϮSEM) and vehicle (5183Ϯ289) treated groups and normal right eye controls (day 0; BDNF: 4980Ϯ285; vehicle: 4594Ϯ330). With BDNF treatment, the number of RGCs decreased slightly, but not significantly, at 7 days (4186Ϯ183); however, with vehicle treatment, RGC cell profiles declined significantly (3003Ϯ283; PϽ0.05). By 10 and 14 days following optic nerve transection and BDNF treatment, RGC profile counts declined to 3517Ϯ221 and 2788Ϯ417, respectively, compared with 1016Ϯ69 and 846Ϯ69 following vehicle treatment. By 28 days, the number of FG-positive RGCs was reduced to 281Ϯ19 with BDNF treatment and 84Ϯ6 with vehicle treatment. At 7, 10, 14 and 28 days following optic nerve transection, there was a significantly greater number (PϽ0.05) of FG-positive RGC profiles in BDNF-treated groups than vehicle-treated groups and these differences were similar to other published results (Mansour-Robaey et al., 1994) . By 14 days following optic nerve transection in the vehicle-treated group, the number of surviving RGCs was reduced to 15% of right eye controls, whereas in the BDNF-treated group, approximately 50% of RGCs remained. By 28 days following axotomy, the number of surviving RGCs was reduced significantly in both treatment groups with 5% of RGCs surviving following There is no significant difference in the number of RGC profiles counted in retinas at 0 (right eye controls) and 4 days following optic nerve transection with either vehicle or BDNF treatment. From 7 to 14 days following optic nerve transection, the number of FG-positive cell profiles is significantly decreased (PϽ0.05) in vehicle-treated retinas when compared with BDNF treated retinas.
BDNF treatment and approximately 2% of RGCs surviving after vehicle treatment.
Immunohistochemical analysis
Hsp27 in RGCs. Hsp27 immunoreactivity was not detected in RGCs of uninjured right retinas, confirming our previous report (Krueger-Naug et al., 2002) . Following optic nerve transection, Hsp27 was detected in RGCs (Fig. 3) and there was a significant increase (PϽ0.05) in the number of Hsp27-positive RGC profiles detected in the ganglion cell layer at 4, 7, 10 and 14 days in both the BDNF and vehicle-treated groups as compared with normal retina (day 0; Fig. 4) . The greatest number of Hsp27-positive RGC profiles was detected at 4 (51Ϯ9, 90Ϯ7; BDNF, vehicle, respectively) and 7 (37Ϯ6, 95Ϯ14; BDNF, vehicle respectively) days with numbers declining to 28 days (10Ϯ2, 9Ϯ2; BDNF, vehicle respectively) in both the BDNF and vehicle-treated groups. The number of Hsp27-positive RGCs in the BDNF treated groups was significantly less (PϽ0.05) than in the vehicle-treated groups at 4, 7, 10 and 14 days following optic nerve transection. By 28 days following axotomy, there was no significant difference between BDNF (10Ϯ2) and vehicle (9Ϯ2) treated groups.
The mean number of Hsp27-positive RGCs was determined as a percentage of FG-positive RGCs (Fig. 5) . Following optic nerve transection and vehicle injection, the percentage of Hsp27-positive RGCs was significantly increased from 1.8% at 4 days to 10.5% at 28 days (PϽ0.05). With enhanced RGC survival following BDNF treatment, the percentage of Hsp27-positive RGCs was significantly lower (PϽ0.05) than in the vehicle-treated groups, ranging from 1.1% at 4 days to 3.6% at 28 days.
Hsp27 was also detected in a small number of RGC profiles in BDNF and vehicle-injected controls at 4 (2Ϯ1 and 8Ϯ1, respectively) and 10 days (3Ϯ1 and 7Ϯ3) (Fig.  6) . The vehicle-injected control retinas had significantly greater numbers of Hsp27-positive RGC profiles (PϽ0.05) than the BDNF-injected controls at 4 days.
Hsp27 in Mü ller cells.
Hsp27 immunofluorescence was detected in some GFAP-positive Mü ller cells in nontransected BDNF and vehicle-injected control retinas, and in transected BDNF and vehicle-treated groups (Fig. 7) . This glial expression varied in location along the radial sections. No Hsp27-positive Mü ller cells were detected in normal (right eye) retinas.
DISCUSSION
Our current research examines the relationship between administration of BDNF and the injury-induced expression of Hsp27 in RGCs following axotomy. BDNF and Hsp27 have been shown individually to be protective in neuronal cells following injury (Mansour-Robaey et al., 1994; Yokoyama et al., 2001 ). Here we show that a single intravitreal injection of BDNF, administered at the time of optic nerve transection, enhances the survival of RGCs to 14 days following injury compared with vehicle-injection. These results are similar to other published reports (Mansour-Robaey et al., 1994; Peinado-Ramó n et al., 1996; Sawai et al., 1996) . Hsp27-immunofluorescent staining is detected in a subset of RGCs following axotomy in both BDNF and vehicle-treated retinas. However, with BDNF treatment, there are significantly fewer Hsp27-positive RGC profiles compared with vehicle-treated retinas from 4 to 14 days following axotomy. By 28 days, there is no significant difference in the number of Hsp27-positive RGCs between BDNF and vehicle-treated retinas. After optic nerve transection and vehicle treatment, retinas show a general increase in the percentage of Hsp27-positive RGCs over time indicating that the Hsp27-positive cell population dies at a slower rate than the general FG population. These results suggest that BDNF suppresses the expression of Hsp27 in axotomized RGCs to 14 days following injury. Past 14 days, the small population of Hsp27-positive cells is decreasing at a slower rate compared with the general FG population with both BDNF and vehicle treatment.
BDNF: short-term protection versus long-term survival of neurons
BDNF treatment of injured RGCs enhances their survival but leads to a reduction in the number of Hsp27-positive RGCs compared with vehicle-treated retinas. This result suggests that the short-term protection afforded to RGCs by a single administration of BDNF is not due to the stress response induction of Hsp27 in the surviving cells. In fact, the number of Hsp27-positive RGC profiles in both the BDNF-injected axotomized (Fig. 4) and non-axotomized retinas is less (Fig. 6 ) compared with vehicle injection indicating a general suppression of Hsp27 expression by BDNF.
Prolonged intravitreal administration of neurotrophin following optic nerve transection, either by repeated intravitreal injections (Mansour-Robaey et al., 1994) or by release from an osmotic mini-pump (Clarke et al., 1998) fails to maintain long-term survival of RGCs. It was proposed that long-term administration of various neurotrophins may actually down-regulate receptor function, consistent with the observation that BDNF down-regulates its own receptor (TrkB) following ligand binding (Frank et al., 1996; Sommerfeld et al., 2000) . The reduction in the number of Hsp27-positive RGCs following BDNF treatment between 4 and 14 days indicates that the use of an exogenously applied protective molecule such as BDNF may not only down-regulate its own signaling response but may also suppress alternate, endogenous cell survival pathways which are important for the long term survival of these neurons. It is interesting that as the efficacy of BDNF wanes, we detect an increase in the percentage of RGCs that are Hsp27-positive (see Fig. 5 ).
Hsp27 and neuroprotection
By 28 days following axotomy, in both BDNF and vehicletreated groups, there is a significant increase in the percentage of Hsp27-positive RGCs. The increased percentage of Hsp27-positive RGCs suggests that Hsp27 plays a role in promoting long-term sensory neuron survival. We proposed in our previous work that the expression of Hsp27 in a subset of RGCs may help to sustain these cells in the long-term (Krueger-Naug et al., 2002a) . Indeed, a small population of RGCs survives in the retina up to 3 months following transection (Villeges-Pé rez et al., 1993) .
Several studies have reported a correlation between neuron survival and Hsp27 expression. In the adult rat, Hsp27 is constitutively expressed in dorsal root ganglion (DRG) cells (Plumier et al., 1997c; Costigan et al., 1998) . Following peripheral nerve axotomy in the adult rat, Hsp27 expression is further elevated in these cells and most neurons survive for months following the injury (Hopkins et al., 1998; Costigan et al., 1998; Lewis et al., 1999) . However, at postnatal day 0, little or no Hsp27 is detected in DRG neurons and few of these cells survive axotomy. It is interesting to note, however, that of the few DRG cells that survive axotomy at postnatal day 0, all are Hsp27-positive (Lewis et al., 1999) . In addition, cultured neurons that express Hsp27 or over-express human Hsp27 preferen- tially survive nerve growth factor withdrawal (Lewis et al., 1999) . Our study suggests a correlation between Hsp27 expression and the long-term survival of a small population of RGCs.
Signaling in RGCs: Anti-apoptotic action of Hsp27
In addition to microfilament binding (Lavoie, 1993a (Lavoie, , 1993b (Lavoie, , 1995 Hout et al., 1996 Hout et al., , 1997 and preventing protein aggregation (Jakob et al., 1993; Merck et al., 1993) , Hsp27 has been shown to interfere with both receptor/ligand mediated and mitochondrial-mediated programmed cell death. Hsp27 over-expression has been shown to inhibit apoptosis induced by Fas/APO-1 receptor activation (Mehlen et al., 1996; Samali and Cotter, 1996) and DaxxAsk1-dependent Fas-induced cell death (Charette et al., 2000) . Recent studies suggest that Hsp27 interferes with the mitochondrial pathway of caspase-dependent cell death including the blockade of cytochrome-C-mediated activation of caspase-3 and -9 (Garrido et al., 1999; Bruey et al., 2000; Pandey et al., 2000) and negatively regulating cytochrome C release from the mitochondria (Paul et al., 2002) . Activation of caspase-3 is reported to be the crucial step leading to neuronal apoptotic death (Nicholson and Thornberry, 1997) and caspase-9 functions as the upstream activator of caspase-3 . In the retina, inhibition of caspase-3 and caspase-9 activation has significantly improved the survival of RGCs following optic nerve transection (Chaudhary et al., 1999; Garrido et al., 1999; Kermer et al., 1999 Kermer et al., , 2000 Pandey et al., 2000) . Hsp27 may play a direct role in the blockade of caspase activation in the subset of Hsp27-positive RGCs following optic nerve transection and may lead to the long-term protection of this small population of neurons. The specificity with which Hsp27 inhibits these caspases via negative regulation of cytochrome C may indicate an important therapeutic role for this protein in preventing apoptosis of RGCs following optic nerve transection. Recently, the introduction of Hsp27 protein into RGCs by electroporation has been shown to rescue RGCs from apoptosis associated with ischemia-reperfusion injury (Yokoyama et al., 2001 ). In the glaucomatous retina, antibodies to Hsp27 have been shown to induce RGC apoptosis (Tezel and Wax, 2000) . Induction of endogenous Hsp27 as well as the introduction of exogenous protein prior to injury may prove beneficial for RGC survival following injury.
Signaling in RGCs: BDNF modulates Hsp27 expression
The present work shows that the administration of BDNF rescues RGCs in the short-term (Fig. 2) , but at the same time suppresses the expression of the Hsp27, following optic nerve transection (Fig. 4) . BDNF activates two important intracellular signaling pathways when bound to its high affinity receptor TrkB that afford RGCs protection from apoptosis: the Ras (GTP binding protein)/mitogen-activated protein kinase (MAPK) pathway and the phosphatidyl-inositol-3'-kinase/protein kinase B (PI-3-K/PKB) pathway .
Interestingly, the activation of two key components of the Ras/MAPK pathway, MAPK (ERK) and p90RSK2 have recently been shown to have an inhibitory effect on heat shock transcription factor 1 (HSF1), the transcription factor responsible for Hsp transcription (reviewed in Morimoto et al., 1994) . Activated MAPK (ERK) represses HSF1 function by phosphorylation, blocking its ability to initiate heat shock gene transcription (Chu et al., 1996) . Also, p90RSK2, which is activated by MAPK represses HSF1 function during stress (Wang et al., 2000) .
In neurons, the activation of the Ras/MAPK pathway is primarily related to stimuli involved in developmental neuronal survival and neurite outgrowth (reviewed in Heumann, 1994) . Chu et al. (1996) hypothesize that activation of the stress response, which blocks the transcription of normal genes and enhances the transcription of the heat shock genes (Ritossa et al., 1962; Tissiè res et al., 1974) , would be deleterious to cell survival during growth and development. The activation of the Ras/MAPK pathway by BDNF effectively represses HSF1 regulated expression of heat shock genes during growth and development. In vitro, the artificial activation of MAPK and p90RSK2 have also been shown to repress the activation of HSF1 following heat shock (Chu et al., 1996 (Chu et al., , 1998 Wang et al., 2000) . Although the suppression of HSF1 is important during development to allow for the proper expression of developmentally regulated genes (Chu et al., 1996) , its suppression following injury in the adult rat CNS may be detrimental to some neurons. The results presented here represent the first in vivo study indicating that the activation of neurotrophin-specific cell survival pathways may suppress other endogenous pathways important for the long-term survival of injured neurons. The expression of Hsp27 in some cells may indicate the incomplete diffusion or insufficient exposure of all RGCs to the exogenously applied BDNF.
There is growing evidence suggesting that BDNF may interfere with other signaling pathways that may limit its neuroprotective potential. It is well established that repeated intraocular injections of BDNF fail to prevent the death of axotomized RGCs in the long term (MansourRobaey et al., 1994) . Although it has been shown that BDNF may down-regulate the expression of its own receptor, TrkB (Frank et al., 1996; Sommerfeld et al., 2000) , exogenous application of BDNF may also cause other undesirable side effects. Following optic nerve transection, Klö cker et al. (1998) have shown that exogenously applied BDNF increases the formation of nitric oxide through the activation of retinal nitric oxide synthase. The upregulation of free radical formation and the suppression of the putative neuroprotective molecule Hsp27 may help to explain the inability of exogenous BDNF to ensure the long-term survival of injured RGCs.
Cell type-specific and stress-dependent expression of Hsp27
Optic nerve transection induces the expression of Hsp27 in a limited population of RGCs (Fig. 4) which is in agreement with results from previously reported work (Krueger-Naug et al., 2002a) . The detection of Hsp27 in a few RGCs in our injection-only control retinas (Fig. 6) suggests that the injection procedure also causes the expression of Hsp27 in a limited number of RGCs.
Hsp27 was detected in some Mü ller cells (the primary glial cells of the retina) in both BDNF or vehicle-injected groups after optic nerve transection, and in the nontransected injection controls. The expression of Hsp27 in these Mü ller cells was not detected in the retina following optic nerve transection only (Krueger-Naug et al., 2002a) . Glial expression of Hsp27 appears to be specifically related to the injection itself and may be a retinal response to local damage caused by the posterior route of injection that takes the needle through the layers of the retina and into the vitreous chamber. This route of injection is thought to minimize the endogenous retinal trophic response (Mansour-Robaey et al., 1994) . Our results indicate that various types of damage cause cell-type specific expression of Hsp27. Axotomy induces Hsp27 expression only in RGCs, while direct mechanical damage or perturbation of the retina by injection of BDNF or vehicle causes the expression of Hsp27 in some Mü ller cells and in a small number of RGCs.
The stress-dependent expression of Hsp27 in different cell types has been widely reported. In the visual system, optic nerve transection causes only some RGCs to become Hsp27-positive whereas widespread expression of Hsp27 is detected in astrocytes in the retinorecipent layers of the superior colliculus (Krueger-Naug et al., 2002a) . In the peripheral nervous system, sciatic nerve injury and vagotomy have resulted in the induction and prolonged expression of Hsp27 in the affected neurons (Costigan et al., 1998; Hopkins et al., 1998; Lewis et al., 1999) . Hyperthermia causes the induction of Hsp27 primarily in astroglia throughout the CNS; in addition, hyperthermia results in Hsp27 expression in specific nuclei associated with fluid homeostasis and thermoregulation (Krueger-Naug et al., 2000) . With excitotoxic injury such as kainic acid-induced status epilepticus (Plumier et al., 1996) , and potassium chloride-induced cortical spreading depression (Plumier et al., 1997b) , Hsp27 is detected primarily in astrocytes. Our data provide further evidence for the cell-type specific, stress-dependent expression of Hsp27 in the CNS.
CONCLUSIONS
This work provides the first evidence that BDNF suppresses the expression of Hsp27 following injury. These results indicate that neurotrophin treatment may interfere with various cell survival pathways, including the stressinduced expression of Hsp27, and may help to explain the inability of prolonged neurotrophin administration to enhance the long-term survival of injured RGCs. Our study also shows that, by 28 days, the percentage of Hsp27-positive RGCs increases relative to the FG-labeled RGC population studied, suggesting that Hsp27 may be important for some of the few injured sensory neurons that survive long-term. Finally, it is apparent that different injuries cause the induction of Hsp27 in specific cell types, further supporting the notion of the cell-type specific and stress-dependent nature of Hsp27 expression in the CNS.
